Acamprosate

CHEMBL1201293 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

181.2 g/mol

LogP

-1.2

Phase

4

A medication used to help people who have stopped drinking alcohol remain abstinent by reducing the unpleasant physical and emotional symptoms that can occur during prolonged sobriety. It is thought to restore the brain's chemical balance disrupted by long-term alcohol use, easing feelings of anxiety, restlessness, and discomfort that can trigger relapse. It must be taken consistently three times daily and works best when combined with counseling or a support program.

Moleküler Ağırlık

181,2100 g/mol

LogP

-1,20

TPSA

91,90 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Parkinson's Disease Schizophrenia Bipolar Disorder Generalized Anxiety Disorder Major Depressive Disorder

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(=O)NCCCS(=O)(=O)O

InChI

InChI=1S/C5H11NO4S/c1-5(7)6-3-2-4-11(8,9)10/h2-4H2,1H3,(H,6,7)(H,8,9,10)

Molecular Formula

C5H11NO4S

HBD / HBA

2 / 4

Döndürülebilir Bağlar

4

Ağır Atomlar

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A medication used to help people who have stopped drinking alcohol remain abstinent by reducing the unpleasant physical and emotional symptoms that can occur during prolonged sobriety. It is thought to restore the brain's chemical balance disrupted by long-term alcohol use, easing feelings of anxiety, restlessness, and discomfort that can trigger relapse. It must be taken consistently three times daily and works best when combined with counseling or a support program.

Yes, Acamprosate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201293. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 71158. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Acamprosate PillFYI'da

Yapı

Hızlı Veriler

Formül: C5H11NO4S
Eş Anlamlılar: 2

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.